Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 02, 2023

BUY
$12.75 - $23.41 $29,325 - $53,843
2,300 New
2,300 $30,000
Q1 2023

Apr 27, 2023

BUY
$12.75 - $23.41 $29,325 - $53,843
2,300 New
2,300 $30,000
Q1 2022

Apr 21, 2022

SELL
$9.12 - $17.47 $22,799 - $43,675
-2,500 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$20.0 - $27.92 $50,000 - $69,800
2,500 New
2,500 $59,000

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $945M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.